NCT02712554View on ClinicalTrials.gov

A Study in Opioid-Experienced, Non-Dependent Recreational Drug Users to Determine the Abuse Potential and Safety of CL-108 Tablets Administered Via the Oral Route

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
PainNauseaVomiting
Interventions
DRUG

CL-108

7.5 mg/325 mg/12.5 mg tablet

DRUG

M366

7.5 mg/325 mg tablet

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Charleston Laboratories, Inc

INDUSTRY

NCT02712554 - A Study in Opioid-Experienced, Non-Dependent Recreational Drug Users to Determine the Abuse Potential and Safety of CL-108 Tablets Administered Via the Oral Route | Biotech Hunter | Biotech Hunter